Opioid signaling and design of analgesics. [PDF]
Prog Mol Biol Transl Sci, 2023 Paul B, Sribhashyam S, Majumdar S.
europepmc +1 more source
(435) Nausea and vomiting with oliceridine (TRV130), a novel μ receptor G protein Pathway Selective modulator (μ-GPS), vs morphine: an analysis of tolerability from a phase 2b randomized clinical trial [PDF]
The Journal of Pain, 2016 H. Minkowitz +4 more
openaire +1 more source
Opioids and opioid receptors; understanding pharmacological mechanisms as a key to therapeutic advances and mitigation of the misuse crisis. [PDF]
BJA Open, 2023 Lambert DG.
europepmc +1 more source
Structural Modification and Development of <i>N</i>-(1,2,3,4-Tetrahydro-3-isoquinolinylmethyl)benzamide, BPR1M492, as a Potent and Rapid-Onset Opioid Analgesic with Reduced Withdrawal Symptoms. [PDF]
J Med ChemChang PW +13 more
europepmc +1 more source
Role of β-arrestin-2 in short- and long-term opioid tolerance in the dorsal root ganglia. [PDF]
Eur J Pharmacol, 2021 Muchhala KH +3 more
europepmc +1 more source
Knowledge graph and emerging trends in β-arrestin research on pain: a bibliometric analysis (1997-2025). [PDF]
Naunyn Schmiedebergs Arch PharmacolYu H, Ding X, Zhang Y, Yu Y, Wang X.
europepmc +1 more source
Three-Dimensional Structural Insights Have Revealed the Distinct Binding Interactions of Agonists, Partial Agonists, and Antagonists with the µ Opioid Receptor. [PDF]
Int J Mol Sci, 2023 Li Z +7 more
europepmc +1 more source
(432) Respiratory safety signal with oliceridine (TRV130), a novel μ receptor G protein pathway selective modulator (μ-GPS), vs morphine: a safety analysis of a Phase 2b randomized clinical trial [PDF]
The Journal of Pain, 2016 N. Singla +4 more
openaire +1 more source
Biased Opioid Receptor Agonists: Balancing Analgesic Efficacy and Side-Effect Profiles. [PDF]
Int J Mol SciJu J, Li Z, Liu J, Peng X, Gao F.
europepmc +1 more source
Overview and Prospects of the Clinical Application of Oliceridine. [PDF]
Drug Des Devel TherYi K, Sun W, Yu W, Chen S.
europepmc +1 more source